QINLOCK
Live / Registered — Registered (as of 29 Sept 2020)
What this means for you
Registered since 29 Sept 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88680336
- Registration number
- 6165745
- Mark type
- Stylized text
- Filed
- 05 Nov 2019
- Published for opposition
- 12 May 2020
- Registered
- 29 Sept 2020
- Attorney of record
- Jessica L. Rothstein
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical oncology treatments, namely, preparations for gastrointestinal stromal tumors, systemic mastocytosis, glioma, non-small cell lung cancer, germ cell cancer, penile cancer, melanoma and soft tissue sarcoma
- Class 044 — Medical, beauty and agricultural services: medical services, namely, medical treatment for gastrointestinal stromal tumors, systemic mastocytosis, glioma, non-small cell lung cancer, germ cell cancer, penile cancer, melanoma and soft tissue sarcoma
Owner
- Deciphera Pharmaceuticals, LLC, Waltham, MA, US
- Deciphera Pharmaceuticals, LLC, Waltham, MA, US
- Deciphera Pharmaceuticals, LLC, Waltham, MA, US
Prosecution history
- 29 Sept 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 29 Sept 2020 — REGISTERED-PRINCIPAL REGISTER
- 25 Aug 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 24 Aug 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 13 Aug 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Aug 2020 — STATEMENT OF USE PROCESSING COMPLETE
- 27 Jul 2020 — USE AMENDMENT FILED
- 12 Aug 2020 — SOU EXTENSION 1 GRANTED
- 27 Jul 2020 — SOU EXTENSION 1 FILED
- 12 Aug 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 27 Jul 2020 — SOU TEAS EXTENSION RECEIVED
- 27 Jul 2020 — TEAS STATEMENT OF USE RECEIVED
- 07 Jul 2020 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 12 May 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 12 May 2020 — PUBLISHED FOR OPPOSITION